Clearside Biomedical, Inc. Liquidation Value Calculator
Clearside Biomedical, Inc.
Current Price: N/A
Loading calculator data...
Advanced: All 80 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| accounts_payable | ||||
| Accounts Payable Current total AccountsPayableCurrent |
$796,000 | USD | ||
| accounts_receivable | ||||
| Accounts Receivable Net Current total AccountsReceivableNetCurrent |
$266,000 | USD | ||
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$6.80M | USD | ||
| Cash Cash Equivalents And Short Term Investments total CashCashEquivalentsAndShortTermInvestments |
$6.80M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations |
$6.80M | USD | ||
| current_liabilities | ||||
| Accrued Liabilities Current total AccruedLiabilitiesCurrent |
$1.59M | USD | ||
| Employee Related Liabilities Current total EmployeeRelatedLiabilitiesCurrent |
$0 | USD | ||
| Operating Lease Liability Current total OperatingLeaseLiabilityCurrent |
$384,000 | USD | ||
| Other Accrued Liabilities Current total OtherAccruedLiabilitiesCurrent |
$90,000 | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$2.77M | USD | ||
| liabilities_total | ||||
| Liabilities total | $65.59M | USD | ||
| operating_lease_liability | ||||
| Operating Lease Liability Current fact OperatingLeaseLiabilityCurrent |
$384,000 | USD | ||
| Operating Lease Liability Noncurrent fact OperatingLeaseLiabilityNoncurrent |
$62,000 | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
5.2M | shares | ||
Unmapped Tags (64)
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | $1.40M | USD | ||
| Additional Paid In Capital AdditionalPaidInCapital | $319.94M | USD | ||
| Assets Assets | $11.64M | USD | ||
| Assets Current AssetsCurrent | $8.25M | USD | ||
| Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss | $0 | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $26.67M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $5.23M | shares | ||
| Common Stock Value CommonStockValue | $78,000 | USD | ||
| Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage | $0 | pure | ||
| Investment Income Interest InvestmentIncomeInterest | $343,000 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $11.64M | USD | ||
| Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset | $376,000 | USD | ||
| Other Assets Current OtherAssetsCurrent | $0 | USD | ||
| Other Assets Noncurrent OtherAssetsNoncurrent | $30,000 | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $10.00M | shares | ||
| Preferred Stock Shares Issued PreferredStockSharesIssued | $0 | shares | ||
| Preferred Stock Value PreferredStockValue | $0 | USD | ||
| Property Plant And Equipment Gross PropertyPlantAndEquipmentGross | $4.38M | USD | ||
| Property Plant And Equipment Net PropertyPlantAndEquipmentNet | $2.98M | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-373.96M | USD | ||
| Stockholders Equity StockholdersEquity | $-53.95M | USD | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | $746,000 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | $-13.22M | USD | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | $-2.03M | USD | ||
| Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue | $0 | USD | ||
| Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet | $36,000 | USD | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | $199,000 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $2.83M | USD | ||
| Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities | $-9,000 | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-16.04M | USD | ||
| Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment | $9,000 | USD | ||
| Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments | $0 | USD | ||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | $23,000 | USD | ||
| Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments | $0 | USD | ||
| Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised | $0 | USD | ||
| Share Based Compensation ShareBasedCompensation | $2.16M | USD | ||
| Accrued Income Taxes AccruedIncomeTaxes | $692,000 | USD | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | $1.72M | shares | ||
| Cost Of Goods And Services Sold CostOfGoodsAndServicesSold | $248,000 | USD | ||
| Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit | $641.00M | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-4 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-4 | USD/shares | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $9.61M | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | $-17.98M | USD | ||
| Income Tax Expense Benefit IncomeTaxExpenseBenefit | $715,000 | USD | ||
| Net Income Loss NetIncomeLoss | $-18.69M | USD | ||
| Operating Costs And Expenses OperatingCostsAndExpenses | $18.84M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-15.81M | USD | ||
| Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax | $18.69M | USD | ||
| Other General And Administrative Expense OtherGeneralAndAdministrativeExpense | $1.10M | USD | ||
| Other Research And Development Expense OtherResearchAndDevelopmentExpense | $1.20M | USD | ||
| Prepaid Expense Current PrepaidExpenseCurrent | $1.19M | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $8.98M | USD | ||
| Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax | $3.02M | USD | ||
| Accrued Professional Fees Current AccruedProfessionalFeesCurrent | $460,000 | USD | ||
| Depreciation Depreciation | $253,000 | USD | ||
| Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet | $0 | USD | ||
| Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants | $-5.50M | USD | ||
| Profit Loss ProfitLoss | $-18.69M | USD | ||
| Severance Costs1 SeveranceCosts1 | $2.30M | USD | ||
| Severance Costs1 SeveranceCosts1 | $2.60M | USD | ||
| Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | $10,000 | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.